These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29056865)

  • 1. 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose Binds to the N-terminal Metal Binding Region to Inhibit Amyloid
    de Almeida NEC; Do TD; LaPointe NE; Tro M; Feinstein SC; Shea JE; Bowers MT
    Int J Mass Spectrom; 2017 Sep; 420():24-34. PubMed ID: 29056865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposing Effects of Cucurbit[7]uril and 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranose on Amyloid β25-35 Assembly.
    de Almeida NE; Do TD; Tro M; LaPointe NE; Feinstein SC; Shea JE; Bowers MT
    ACS Chem Neurosci; 2016 Feb; 7(2):218-26. PubMed ID: 26629788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A traditional medicinal herb Paeonia suffruticosa and its active constituent 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose have potent anti-aggregation effects on Alzheimer's amyloid beta proteins in vitro and in vivo.
    Fujiwara H; Tabuchi M; Yamaguchi T; Iwasaki K; Furukawa K; Sekiguchi K; Ikarashi Y; Kudo Y; Higuchi M; Saido TC; Maeda S; Takashima A; Hara M; Yaegashi N; Kase Y; Arai H
    J Neurochem; 2009 Jun; 109(6):1648-57. PubMed ID: 19457098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of C-Terminal Fragments of Amyloid β-Protein as Aβ Inhibitors: Do C-Terminal Interactions Play a Key Role in Their Inhibitory Activity?
    Zheng X; Wu C; Liu D; Li H; Bitan G; Shea JE; Bowers MT
    J Phys Chem B; 2016 Mar; 120(8):1615-23. PubMed ID: 26439281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norepinephrine Inhibits Alzheimer's Amyloid-β Peptide Aggregation and Destabilizes Amyloid-β Protofibrils: A Molecular Dynamics Simulation Study.
    Zou Y; Qian Z; Chen Y; Qian H; Wei G; Zhang Q
    ACS Chem Neurosci; 2019 Mar; 10(3):1585-1594. PubMed ID: 30605312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.
    Zhang W; Du Y; Bai M; Xi Y; Li Z; Miao J
    J Pept Sci; 2013 Mar; 19(3):159-65. PubMed ID: 23349038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
    Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
    Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential inhibitory effect of β-casein on the aggregation and deposition of Aβ
    Hojati S; Ghahghaei A; Lagzian M
    J Biomol Struct Dyn; 2018 Jun; 36(8):2118-2130. PubMed ID: 28633568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of N-terminal Mutations on β-amyloid Peptide Aggregation and Toxicity.
    Foroutanpay BV; Kumar J; Kang SG; Danaei N; Westaway D; Sim VL; Kar S
    Neuroscience; 2018 May; 379():177-188. PubMed ID: 29572166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Albumin Impairs Amyloid β-peptide Fibrillation Through its C-terminus: From docking Modeling to Protection Against Neurotoxicity in Alzheimer's disease.
    Picón-Pagès P; Bonet J; García-García J; Garcia-Buendia J; Gutierrez D; Valle J; Gómez-Casuso CES; Sidelkivska V; Alvarez A; Perálvarez-Marín A; Suades A; Fernàndez-Busquets X; Andreu D; Vicente R; Oliva B; Muñoz FJ
    Comput Struct Biotechnol J; 2019; 17():963-971. PubMed ID: 31360335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics simulations reveal the mechanism of graphene oxide nanosheet inhibition of Aβ
    Jin Y; Sun Y; Chen Y; Lei J; Wei G
    Phys Chem Chem Phys; 2019 Jun; 21(21):10981-10991. PubMed ID: 31111835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abeta20-29 peptide blocking apoE/Abeta interaction reduces full-length Abeta42/40 fibril formation and cytotoxicity in vitro.
    Hao J; Zhang W; Zhang P; Liu R; Liu L; Lei G; Su C; Miao J; Li Z
    Neuropeptides; 2010 Aug; 44(4):305-13. PubMed ID: 20363024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study.
    Sun Y; Qian Z; Wei G
    Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary: Abeta N- Terminal Isoforms: Critical contributors in the course of AD pathophysiology.
    Tekirian TL
    J Alzheimers Dis; 2001 Apr; 3(2):241-248. PubMed ID: 12214065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc-induced heterodimer formation between metal-binding domains of intact and naturally modified amyloid-beta species: implication to amyloid seeding in Alzheimer's disease?
    Mezentsev YV; Medvedev AE; Kechko OI; Makarov AA; Ivanov AS; Mantsyzov AB; Kozin SA
    J Biomol Struct Dyn; 2016 Nov; 34(11):2317-26. PubMed ID: 26513486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characterization of beta-amyloid oligomer-aggregates by ion mobility mass spectrometry and electron spin resonance spectroscopy.
    Ionuţ Iuraşcu M; Cozma C; Tomczyk N; Rontree J; Desor M; Drescher M; Przybylski M
    Anal Bioanal Chem; 2009 Dec; 395(8):2509-19. PubMed ID: 19838688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidylcholine increases the neurotoxicity of Alzheimer's amyloid β1-42 peptide: role of oligomer formation.
    Sheikh AM; Michikawa M; Kim SU; Nagai A
    Neuroscience; 2015 Apr; 292():159-69. PubMed ID: 25727637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Amyloid β-Protein (Aβ) Assembly by Homologous C-Terminal Fragments as a Strategy for Inhibiting Aβ Toxicity.
    Li H; Rahimi F; Bitan G
    ACS Chem Neurosci; 2016 Jul; 7(7):845-56. PubMed ID: 27322435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.